TerrAscend Announces Results of Annual General Meeting
TerrAscend (OTCQX: TSNDF), a leading North American cannabis company, announced the results of its annual general meeting held on June 24, 2025. Shareholders approved three key resolutions: the re-election of five directors with strong approval rates above 97%, the re-appointment of MNP LLP as auditors with 99.39% approval, and the modification of exercise prices for 3.7M insider stock options with 79.58% support.
Notable director re-elections include Jason Wild receiving the highest approval at 99.61%, while Kara DioGuardi received 97.96% approval. The stock option modification resolution, which affects insider holdings, passed despite a more significant opposition of 20.42%.
TerrAscend (OTCQX: TSNDF), una delle principali aziende nordamericane nel settore della cannabis, ha annunciato i risultati della sua assemblea generale annuale tenutasi il 24 giugno 2025. Gli azionisti hanno approvato tre risoluzioni chiave: la rielezione di cinque amministratori con tassi di approvazione superiori al 97%, la riconferma di MNP LLP come revisori contabili con il 99,39% di approvazione e la modifica dei prezzi di esercizio di 3,7 milioni di stock option interne con il 79,58% di supporto.
Tra le rielezioni di rilievo, spicca Jason Wild con il più alto tasso di approvazione pari al 99,61%, mentre Kara DioGuardi ha ottenuto il 97,96%. La risoluzione sulla modifica delle stock option, che riguarda le partecipazioni interne, è stata approvata nonostante un'opposizione più significativa del 20,42%.
TerrAscend (OTCQX: TSNDF), una empresa líder en cannabis en Norteamérica, anunció los resultados de su junta general anual celebrada el 24 de junio de 2025. Los accionistas aprobaron tres resoluciones clave: la reelección de cinco directores con tasas de aprobación superiores al 97%, la reelección de MNP LLP como auditores con un 99,39% de aprobación y la modificación de los precios de ejercicio para 3,7 millones de opciones sobre acciones internas con un 79,58% de apoyo.
Entre las reelecciones destacadas, Jason Wild obtuvo la mayor aprobación con un 99,61%, mientras que Kara DioGuardi recibió un 97,96%. La resolución sobre la modificación de las opciones sobre acciones, que afecta a las participaciones internas, fue aprobada a pesar de una oposición más significativa del 20,42%.
TerrAscend (OTCQX: TSNDF)는 북미를 선도하는 대마초 회사로서 2025년 6월 24일에 개최된 연례 주주총회 결과를 발표했습니다. 주주들은 세 가지 주요 결의를 승인했는데, 5명의 이사 재선임은 97% 이상의 높은 찬성률을 기록했고, MNP LLP의 감사 재선임은 99.39%의 찬성을 받았으며, 370만 주의 내부자 스톡옵션 행사가격 수정은 79.58%의 지지를 얻었습니다.
특히 이사 재선임 중 Jason Wild가 99.61%로 가장 높은 찬성을 받았고, Kara DioGuardi는 97.96%의 찬성을 받았습니다. 내부자 지분에 영향을 미치는 스톡옵션 수정 결의안은 20.42%의 반대에도 불구하고 통과되었습니다.
TerrAscend (OTCQX : TSNDF), une entreprise leader du cannabis en Amérique du Nord, a annoncé les résultats de son assemblée générale annuelle tenue le 24 juin 2025. Les actionnaires ont approuvé trois résolutions clés : la réélection de cinq administrateurs avec des taux d'approbation supérieurs à 97 %, la reconduction de MNP LLP en tant qu'auditeurs avec 99,39 % d'approbation, et la modification des prix d'exercice de 3,7 millions d'options d'achat d'actions internes avec un soutien de 79,58 %.
Parmi les réélections notables, Jason Wild a obtenu la plus forte approbation avec 99,61 %, tandis que Kara DioGuardi a reçu 97,96 %. La résolution concernant la modification des options d'achat d'actions, qui concerne les participations internes, a été adoptée malgré une opposition plus importante de 20,42 %.
TerrAscend (OTCQX: TSNDF), ein führendes nordamerikanisches Cannabisunternehmen, gab die Ergebnisse seiner Jahreshauptversammlung bekannt, die am 24. Juni 2025 stattfand. Die Aktionäre stimmten drei wichtigen Beschlüssen zu: der Wiederwahl von fünf Direktoren mit Zustimmungsraten über 97 %, der Wiederbestellung von MNP LLP als Wirtschaftsprüfer mit 99,39 % Zustimmung und der Anpassung der Ausübungspreise für 3,7 Millionen Insider-Aktienoptionen mit 79,58 % Unterstützung.
Besonders hervorzuheben sind die Wiederwahlen der Direktoren: Jason Wild erhielt die höchste Zustimmung mit 99,61 %, während Kara DioGuardi 97,96 % Zustimmung erhielt. Der Beschluss zur Änderung der Aktienoptionen, der Insider-Beteiligungen betrifft, wurde trotz eines größeren Widerstands von 20,42 % angenommen.
- None.
- None.
TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF), a leading North American cannabis company, today announced the results of its annual meeting of shareholders held on June 24, 2025 (the "Meeting"). Common shareholders at the Meeting affirmatively approved the following resolutions:
- The re-election of Mr. Craig Collard, Ms. Ira Duarte, Mr. Ed Schutter, Ms. Kara DioGuardi and Mr. Jason Wild as directors of the Company for the ensuing year, the voting results of which are as follows;
| Director | Number of Shares | |
| For | Withheld | |
| Craig Collard | 154,140,823 (99.53 %) | 726,722 ( |
| Ira Duarte | 154,141,122 ( | 726,723 ( |
| Ed Schutter | 154,142,148 ( | 725,397 ( |
| Kara DioGuardi | 151,700,891( | 3,166,954 ( |
| Jason Wild | 154,261,935 ( | 605,910 ( |
- the ratification of the re-appointment of MNP LLP, as the auditor and independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025 and the authorization of the board of directors of the Company to fix their remuneration; and
| Number of Shares | |
| For | Withheld |
| 193,909,629 ( | 1,193,696 ( |
- the approval of a resolution to modify the exercise prices of an aggregate of 3,706,250 stock options of the Company held by certain insiders of the Company, subject to the insider meeting a service period requirement, from their current respective exercise prices to the exercise prices set forth in the Company’s Management Information Circular and Proxy Statement dated April 28, 2025.
| Number of Shares | |
| For | Against |
| 49,849,207 ( | 12,793,583 ( |
About TerrAscend
TerrAscend is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including vertically integrated operations in Pennsylvania, New Jersey, Maryland, Michigan, Ohio and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend operates The Apothecarium, Gage and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. For more information visit www.terrascend.com.
Caution Regarding Cannabis Operations in the United States
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the U.S. Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.
While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve TerrAscend of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against TerrAscend. The enforcement of federal laws in the United States is a significant risk to the business of TerrAscend and any proceedings brought against TerrAscend thereunder may adversely affect TerrAscend’s operations and financial performance.
For more information regarding TerrAscend:
Ziad Ghanem
Chief Executive Officer
IR@terrascend.com
717-343-5386
Investor Relations Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
Valter@KCSA.com
212-896-1254
FAQ
What were the key results of TerrAscend's (TSNDF) 2025 annual general meeting?
Who are the directors re-elected to TerrAscend's board in 2025?
What was the voting result for TerrAscend's stock option modification proposal?
Who received the highest shareholder approval among TerrAscend's directors?
